About GIMDX
GIMDX is a company based in Carlsbad (United States) founded in 2014 by Larry Ziye Liu. It operates as a B2B and Distribution. GIMDX offers products and services including IMPROSAFE® Multi-Sample Needles, IMPROVACUTER® No Additive Tube, IMPROVACUTER® Clot Activator Tubes, IMPROVACUTER® Lithium Heparin Tubes, and Automatic Homogenization Processor. GIMDX operates in a competitive market with competitors including Reaction Biology, ImmunoSCAPE, PhenoVista, Discovery Biomed and BCI Pharma, among others.
- Headquarter Carlsbad, United States
- Founders Larry Ziye Liu
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Gimdx, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GIMDX
GIMDX offers a comprehensive portfolio of products and services, including IMPROSAFE® Multi-Sample Needles, IMPROVACUTER® No Additive Tube, IMPROVACUTER® Clot Activator Tubes, IMPROVACUTER® Lithium Heparin Tubes, and Automatic Homogenization Processor.
Needles for safe multi-sample blood collection in medical procedures.
Tubes for blood sample storage without additives.
Tubes that promote clotting for diagnostic testing.
Tubes using heparin to prevent clotting in samples.
Device for automated fecal specimen preparation in labs.
Funding Insights of GIMDX
Detailed funding history for GIMDX
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GIMDX
Investment portfolio details for GIMDX
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GIMDX
Detailed financials for GIMDX
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gimdx Comparisons
Peer comparison for GIMDX
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GIMDX
GIMDX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Reaction Biology, ImmunoSCAPE, PhenoVista, Discovery Biomed and BCI Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling
|
|
| Locked | Locked | Locked |
High-dimensional immune profiling services are delivered via proprietary platform.
|
|
| Locked | Locked | Locked |
A CRO that provides phenotypic assay development and screening services.
|
|
| Locked | Locked | Locked |
Custom human cell engineering and drug discovery services are provided.
|
|
| Locked | Locked | Locked |
Contract research services in cancer and neuroinflammation are offered.
|
|
| Locked | Locked | Locked |
Specialised CRO offering a range of screening platforms for cardiac safety testing, ion channel profiling and in vitro HTS screening
|
Detailed competitors of GIMDX
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gimdx
Complete news archive for GIMDX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GIMDX
GIMDX was founded in 2014.
GIMDX is headquartered in Carlsbad, United States. It is registered at Carlsbad, California, United States.
Larry Ziye Liu is the current CEO of GIMDX. They have also founded this company.
Improve Medical USA, as a subsidiary of a Chinese company, imports and distributes FDA-registered products like blood collection tubes and needles in the US market. They focus on enhancing accuracy and efficiency in sample collection processes through laboratory automation and safety features. Based in Carlsbad, California, they serve healthcare providers via distribution and OEM partnerships, ensuring high-quality medical supplies for professionals.
GIMDX's top competitors include ImmunoSCAPE, Quantumcyte and Reaction Biology.
GIMDX offers IMPROSAFE® Multi-Sample Needles, IMPROVACUTER® No Additive Tube, IMPROVACUTER® Clot Activator Tubes, IMPROVACUTER® Lithium Heparin Tubes, and Automatic Homogenization Processor.